{"organizations": [], "uuid": "c2f74dba68a2a889cc977e1fe5dbe3b0ae6f991a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cerus-redes-phase-3-red-blood-cell/brief-cerus-redes-phase-3-red-blood-cell-study-expands-into-the-continental-u-s-idUSFWN1RF09R", "country": "US", "domain_rank": 408, "title": "BRIEF-Cerus’ Redes Phase 3 Red Blood Cell Study Expands Into The Continental U.S.", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-02T15:48:00.000+03:00", "replies_count": 0, "uuid": "c2f74dba68a2a889cc977e1fe5dbe3b0ae6f991a"}, "author": "", "url": "https://www.reuters.com/article/brief-cerus-redes-phase-3-red-blood-cell/brief-cerus-redes-phase-3-red-blood-cell-study-expands-into-the-continental-u-s-idUSFWN1RF09R", "ord_in_thread": 0, "title": "BRIEF-Cerus’ Redes Phase 3 Red Blood Cell Study Expands Into The Continental U.S.", "locations": [], "entities": {"persons": [], "locations": [{"name": "houston", "sentiment": "none"}], "organizations": [{"name": "continental", "sentiment": "negative"}, {"name": "baylor", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "cerus corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "continental u.s. reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2, 2018 / 12:49 PM / a few seconds ago BRIEF-Cerus’ Redes Phase 3 Red Blood Cell Study Expands Into The Continental U.S. Reuters Staff \nApril 2 (Reuters) - Cerus Corp: \n* ‘ REDES PHASE 3 RED BLOOD CELL STUDY EXPANDS INTO THE CONTINENTAL U.S. \n* BAYLOR ST. LUKE’S MEDICAL CENTER IN HOUSTON BECAME FIRST CENTER IN CONTINENTAL U.S. TO ENROLL PATIENTS IN CO’S REDES STUDY \n* EXPECT SEVERAL MORE SITES IN CONTINENTAL U.S. TO BEGIN ENROLLING PATIENTS FOR REDES STUDY IN COMING MONTHS Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)", "external_links": [], "published": "2018-04-02T15:48:00.000+03:00", "crawled": "2018-04-02T16:04:13.004+03:00", "highlightTitle": ""}